Korevaar Tim I M, de Rijke Yolanda B, Chaker Layal, Medici Marco, Jaddoe Vincent W V, Steegers Eric A P, Visser Theo J, Peeters Robin P
1 The Generation R Study Group, Erasmus Medical Center , Rotterdam, The Netherlands .
2 Department of Internal Medicine, Erasmus Medical Center , Rotterdam, The Netherlands .
Thyroid. 2017 Mar;27(3):440-450. doi: 10.1089/thy.2016.0527. Epub 2017 Feb 8.
Thyroid autoimmunity is a major risk factor for gestational thyroid disease, and recently various other risk factors have been identified, including maternal age, body mass index (BMI) and parity. Human chorionic gonadotropin (hCG) is an important determinant of gestational thyroid function, yet it is unknown to what extent differences in hCG concentration affect the risk for thyroid disease. We have recently shown that thyroperoxidase antibody positivity impairs the thyroidal response to hCG stimulation, which may suggest that this is a mechanism through which thyroid autoimmunity acts as a risk factor for thyroid disease.
The purpose of this study is to determine whether hCG is a risk factor for thyroid disease entities and whether recently identified risk factors for thyroid disease may influence the thyroidal response to hCG stimulation.
Human chorionic gonadotropin, thyrotropin (TSH), and free thyroxine (FT4) were measured in 5435 pregnant women participating in a prospective cohort. The association of hCG with thyroid disease entities, and the association of known risk factors with thyroidal response to hCG stimulation were studied using multivariable linear regression models.
Higher hCG concentrations were associated with a higher risk of subclinical and overt hyperthyroidism. Lower hCG concentrations were associated with a higher risk of hypothyroxinemia. In contrast, hCG concentrations were not associated with subclinical hypothyroidism. Further analyses showed that in women with hypothyroxinemia, high hCG concentrations still suppressed TSH. However, in women with subclinical hypothyroidism, high hCG concentrations were not associated with higher FT4. Higher BMI, male fetal sex, and maternal parity >2 were associated with a lower thyroidal response to hCG stimulation.
Human chorionic gonadotropin is associated with the risk of (subclinical) hyperthyroidism and hypothyroxinemia, but not with the risk of (subclinical) hypothyroidism. Women with hypothyroxinemia have a normal response to thyroidal stimulation by hCG, but this was abnormal in women with subclinical hypothyroidism. Known risk factors for thyroid dysfunction (BMI and parity), and also male fetal sex, are associated with a lower thyroidal response to hCG stimulation.
甲状腺自身免疫是妊娠甲状腺疾病的主要危险因素,最近还发现了其他各种危险因素,包括产妇年龄、体重指数(BMI)和产次。人绒毛膜促性腺激素(hCG)是妊娠甲状腺功能的重要决定因素,但hCG浓度差异在多大程度上影响甲状腺疾病风险尚不清楚。我们最近发现甲状腺过氧化物酶抗体阳性会损害甲状腺对hCG刺激的反应,这可能表明这是甲状腺自身免疫作为甲状腺疾病危险因素的一种作用机制。
本研究的目的是确定hCG是否为甲状腺疾病实体的危险因素,以及最近确定的甲状腺疾病危险因素是否会影响甲状腺对hCG刺激的反应。
对参与前瞻性队列研究的5435名孕妇测量了人绒毛膜促性腺激素、促甲状腺激素(TSH)和游离甲状腺素(FT4)。使用多变量线性回归模型研究hCG与甲状腺疾病实体的关联,以及已知危险因素与甲状腺对hCG刺激反应的关联。
较高的hCG浓度与亚临床和显性甲状腺功能亢进风险较高相关。较低的hCG浓度与低甲状腺素血症风险较高相关。相比之下,hCG浓度与亚临床甲状腺功能减退无关。进一步分析表明,在低甲状腺素血症女性中,高hCG浓度仍会抑制TSH。然而,在亚临床甲状腺功能减退女性中,高hCG浓度与较高的FT4无关。较高的BMI、男性胎儿性别和产妇产次>2与甲状腺对hCG刺激的反应较低相关。
人绒毛膜促性腺激素与(亚临床)甲状腺功能亢进和低甲状腺素血症风险相关,但与(亚临床)甲状腺功能减退风险无关。低甲状腺素血症女性对hCG的甲状腺刺激反应正常,但亚临床甲状腺功能减退女性则异常。已知的甲状腺功能障碍危险因素(BMI和产次)以及男性胎儿性别与甲状腺对hCG刺激的反应较低相关。